AstraZeneca PLC (AZN) plummeted -0.46 percent and ended the day at $30.3. The Average Volume of the company is 5.66 Million and P/E (price to earnings) ratio is 21.92, while Forward P/E ratio is 15.4.
UBS Downgrade its coverage for AstraZeneca PLC (AZN) in a note sent to investors on 5-Apr-17. The research firm Downgrade the stock to Neutral. Moreover, Liberum issued Initiated rating for the stock on 9-Mar-17. Leerink Partners also Upgrade the company to Outperform on 9-Dec-16, 2016. Additionally, Liberum Upgrade its ratings on the stock to Buy.
The stock has a Return on Assets of 5.5 percent, Return on Investment of 15 percent and a Return on Equity of 24.9 percent. The company’s market cap is $76.46 Billion.
Now we look at the Moving Averages, the 200-day is 3.78, the 50-day is 3.28 and the 20-day is -1.63. Moving averages are used as a strong indicator for technical stock analysis and it helps investors in figuring out where the stock has been and also help in determining where it may be possibly heading.
Looking forward, the company is expected to report earnings of $1.83 per share for the current quarter. Revenue is expected in between 5.35 Billion and 5.04 Billion with an average of 5.22 Billion.
AstraZeneca PLC (AZN) performance during the last one year Improved 7.72 percent, while its year to date (YTD) performance showed a Positive trend of 14.59 percent. The stock Fell -2.96 percent over the past six months. The stock’s quarterly performance indicates a Positive momentum of 10.11 percent, whereas its last one month trend is Optimistic with 2.5 percent. Its weekly performance showed a downward trend of -2.7 percent.
Profitability analysis helps a great deal in making investment decision. Net profit margin of the company was recorded at 15.2 percent, operating profit margin was 21.3 percent, whereas gross profit margin stands at 82.6 percent. Beta factor was calculated at 0.84.
AstraZeneca PLC (AZN) has 2.53 Billion shares outstanding and 2.5 Billion shares were floated in market. The short ratio in the company’s stock is documented at 5.61 and the short float is around of 1.27%. The stock’s average true range of stands at 0.39, while the relative strength index is 49.25.
Liquidity ratios helps investors to determine a company’s ability to pay off its debts. For the most recent quarter, quick ratio was 0.7, current ratio was 0.9, LT Debt/Equity ratio was 0.98 and Total Debt/Equity ratio was 1.13.